phenyl maleiimide compounds (National Institute of Health)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namephenyl maleiimide compounds (National Institute of Health)
Drug Alias NameCdc25 phosphatase inhibitors (NIH)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell division cycle 25 phosphatase inhibitors
TargetsCell division cycle 25 phosphatase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of Health
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A